Barclays PLC lifted its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 25.7% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 143,337 shares of the company's stock after buying an additional 29,271 shares during the quarter. Barclays PLC owned about 0.35% of Phibro Animal Health worth $3,228,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of PAHC. Brandes Investment Partners LP boosted its stake in Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company's stock valued at $40,521,000 after purchasing an additional 29,071 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company's stock valued at $13,005,000 after acquiring an additional 42,086 shares during the period. Acadian Asset Management LLC grew its stake in shares of Phibro Animal Health by 6.3% in the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock valued at $12,027,000 after acquiring an additional 42,299 shares in the last quarter. Dana Investment Advisors Inc. increased its position in Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company's stock worth $8,619,000 after acquiring an additional 75,546 shares during the period. Finally, American Century Companies Inc. raised its stake in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company's stock worth $5,822,000 after purchasing an additional 189,068 shares in the last quarter. Institutional investors own 99.34% of the company's stock.
Phibro Animal Health Stock Performance
Phibro Animal Health stock remained flat at $21.64 during midday trading on Tuesday. The company had a trading volume of 60,041 shares, compared to its average volume of 160,458. The business has a 50 day moving average price of $23.52 and a two-hundred day moving average price of $20.77. The company has a market cap of $876.48 million, a P/E ratio of 50.33, a P/E/G ratio of 0.58 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98.
Phibro Animal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health's dividend payout ratio (DPR) is 111.63%.
Analyst Upgrades and Downgrades
PAHC has been the topic of a number of recent analyst reports. Bank of America raised their price target on Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a research report on Friday, August 30th. StockNews.com raised Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, December 18th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a "neutral" rating and a $22.00 target price on the stock. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Finally, Barclays lifted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research note on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $20.50.
Read Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
